All Stories

  1. Effects of the first month of lockdown for COVID-19 in Italy: A preliminary analysis on the eyecare system from six centers
  2. FOVEA-SPARING VERSUS COMPLETE INTERNAL LIMITING MEMBRANE PEELING IN VITRECTOMY FOR THE TREATMENT OF MACULAR HOLES
  3. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  4. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  5. Central Serous Chorioretinopathy: Pathogenesis and Management
  6. EPIRETINAL MEMBRANE REMOVAL WITH FOVEAL-SPARING INTERNAL LIMITING MEMBRANE PEELING
  7. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
  8. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications
  9. Treatment of exudative age‐related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega‐3: A randomized trial
  10. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration
  11. Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study
  12. Comparison between invasive and noninvasive techniques of evaluation of microvascular structural alterations
  13. ranibizumab and indomethacin in neovascular age-related macular degeneration
  14. Carotid stiffness is significantly correlated with wall-to-lumen ratio of retinal arterioles
  15. New Methods to Study the Microcirculation
  16. ILM peeling in nontractional diabetic macular edema: review and metanalysis
  17. 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy
  18. Ocular fundus photography with a smartphone device in acute hypertension
  19. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension
  20. Heavy and standard silicone oil: intraocular inflammation
  21. Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy
  22. Intravitreal Anti-Vascular Endothelial Growth Factor Drugs for Retinal Angiomatous Proliferation in Real-Life Practice
  23. Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans
  24. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy
  25. Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery
  26. Trace elements and diabetes: Assessment of levels in tears and serum
  27. Spectral-domain optical coherence tomography findings in idiopathic lamellar macular hole
  28. Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment
  29. Effect of Autologous Serum Eye Drops in Patients with Sjögren Syndrome-related Dry Eye: Clinical and In Vivo Confocal Microscopy Evaluation of the Ocular Surface
  30. Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia
  31. Relationship Between Different Subpopulations of Circulating CD4+T-lymphocytes and Microvascular Structural Alterations in Humans
  32. Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Vertical Cup-to-Disc Ratio
  33. Morphological and Functional Retinal Assessment in Epiretinal Membrane Surgery
  34. From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety
  35. Zebrafish ( Danio rerio ) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases
  36. REDUCTION OF VITREOUS PROSTAGLANDIN E2 LEVELS AFTER TOPICAL ADMINISTRATION OF INDOMETHACIN 0.5%, BROMFENAC 0.09%, AND NEPAFENAC 0.1%
  37. Arteriolar Diameters in Glaucomatous Eyes with Single-Hemifield Damage
  38. Morphological and clinical characteristics of myopic posterior staphyloma in Caucasians
  39. Assessment of a smartphone-based camera for fundus imaging in animals
  40. INDICATIONS AND RESULTS OF A NEW L-SHAPED MACULAR BUCKLE TO SUPPORT A POSTERIOR STAPHYLOMA IN HIGH MYOPIA
  41. Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
  42. Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration
  43. TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH RANIBIZUMAB COMBINED WITH KETOROLAC EYEDROPS OR PHOTODYNAMIC THERAPY
  44. Efficacy and vitreous levels of topical NSAIDs
  45. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy
  46. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation
  47. Therapeutic Potential of Anti-Angiogenic Multitarget N,O -Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy
  48. Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Diabetic Retinopathy
  49. Development of ocular hypertension secondary to tamponade with light versus heavy silicone oil: A systematic review
  50. A Novel Device to Exploit the Smartphone Camera for Fundus Photography
  51. Current Trends about Inner Limiting Membrane Peeling in Surgery for Epiretinal Membranes
  52. Diabetic Retinopathy: Vascular and Inflammatory Disease
  53. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy
  54. Effects of a Long-Term Treatment With Aliskiren or Ramipril on Structural Alterations of Subcutaneous Small-Resistance Arteries of Diabetic Hypertensive Patients
  55. Diameters and Wall-to-Lumen Ratio of Retinal Arterioles in Patients with Retinal Vein Occlusion Before and After Treatment with Dexamethasone Intravitreal Implants
  56. Effect of Palmitoylethanolamide on Visual Field Damage Progression in Normal Tension Glaucoma Patients: Results of an Open-Label Six-Month Follow-Up
  57. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane
  58. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview
  59. Relationship of Wall-to-Lumen Ratio of Retinal Arterioles With Clinic and 24-Hour Blood Pressure
  60. Correlation between clinic and 24 hours blood pressure and wall-to-lumen ratio of retinal arterioles
  61. Acute Dacryocystitis with Empyema of the Lacrimal Sac
  62. Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
  63. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension
  64. Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation
  65. Quality of vision in patients implanted with aspherical and spherical intraocular lens: Intraindividual comparison
  66. Tamponade or Filling Effect: Changes of Forces in Myopic Eyes
  67. Heavy Silicone Oil and Intraocular Inflammation
  68. Etiopathogenesis and Therapy of Epithelial Ingrowth after Descemet’s Stripping Automated Endothelial Keratoplasty
  69. Some Physicochemical Remarks on Spontaneous Emulsification of Vitreal Tamponades
  70. Evaluation of the Efficacy of 50% Autologous Serum Eye Drops in Different Ocular Surface Pathologies
  71. Cognitive Dysfunction and Age-Related Macular Degeneration
  72. Clinical Analysis of Macular Edema with New Software for SD-OCT Imaging
  73. In vitro and ex vivo retina angiogenesis assays
  74. Neurotrophic Keratitis
  75. Ocular tissues and fluids oxidative stress in hares fed on verbascoside supplement
  76. Myopia onset and progression: can it be prevented?
  77. High doses of cobalt induce optic and auditory neuropathy
  78. Acute Dacryocystitis with Empyema of the Lacrimal Sac: Is Immediate Endoscopic Dacryocystorhinostomy Justified?
  79. Aflibercept in wet AMD: specific role and optimal use
  80. Incidence rates of surgically treated rhegmatogenous retinal detachment among manual workers, non-manual workers and housewives in Tuscany, Italy
  81. A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration
  82. Familial Exudative Vitreoretinopathy caused by a Homozygous Mutation inTSPAN12in a Cystic Fibrosis Infant
  83. A novel ex vivo murine retina angiogenesis (EMRA) assay
  84. Corneal oedema and its medical treatment
  85. Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection
  86. Novel aspects of Sjögren’s syndrome in 2012
  87. Recurrent Central Serous Chorioretinopathy after Peripheral Retinal Laser Photocoagulation: A Case Report
  88. INTRAVITREAL PEGAPTANIB SODIUM (MACUGEN) FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
  89. Central Retinal Vein Occlusion Treated with Ozurdex: A Case Report and Review of Literature
  90. Inflammation and Macular Oedema after Pars Plana Vitrectomy
  91. Erythropoietin and Diabetic Retinopathy
  92. Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
  93. Vitreous Mediators in Retinal Hypoxic Diseases
  94. Mechanism of Inflammation in Age-Related Macular Degeneration: An Up-to-Date on Genetic Landmarks
  95. Proliferative Vitreoretinopathy after Eye Injuries: An Overexpression of Growth Factors and Cytokines Leading to a Retinal Keloid
  96. Short-time prone posturing is well-tolerated and reduces the rate of unintentional retinal displacement in elderly patients operated on for retinal detachment
  97. TNF-Alpha Levels in Tears: A Novel Biomarker to Assess the Degree of Diabetic Retinopathy
  98. Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study
  99. Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy
  100. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
  101. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation
  102. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry
  103. Consensus on the diagnosis, treatment and follow-up of patients with age-related macular degeneration eligible for ranibizumab
  104. Defining reference values of trace elements in the tear film: Diagnostic methods and possible applications
  105. Reduction in retinal nerve fiber layer thickness in migraine patients
  106. Pseudo-Foster Kennedy syndrome in a young woman with meningioma infiltrating the superior sagittal sinus
  107. Proteomic Analyses of the Vitreous Humour
  108. Vitreous Analysis in the Management of Uveitis
  109. Mechanism of Inflammation in Age-Related Macular Degeneration
  110. Structural Alterations in Small Resistance Arteries in Obesity
  111. Retinal Angiomatosis and Cystoid Macular Oedema in Coganʼs Syndrome
  112. Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
  113. Predicting the risk of diabetic retinopathy in type 2 diabetic patients
  114. Genetic Predictors of Response to Photodynamic Therapy
  115. Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
  116. Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
  117. Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
  118. Impact of Coagulation-Balance Gene Predictors on Efficacy of Photodynamic Therapy for Choroidal Neovascularization in Pathologic Myopia
  119. Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
  120. Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
  121. INTRAVITREAL BEVACIZUMAB FOR TREATMENT-NAÏVE PATIENTS WITH SUBFOVEAL OCCULT CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
  122. Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up
  123. Endophthalmitis
  124. Multiple Strokes in a Newborn
  125. Selective Serotonin Reuptake Inhibitors: A Review of its Effects on Intraocular Pressure
  126. Intravitreal bevacizumab (Avastin®) injection for neovascular glaucoma: a survey on 23 cases throughout twelve-month follow-up
  127. Gonioscopic Findings in Patients with Type 1 Neurofibromatosis (Von Recklinghausen Disease)
  128. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma
  129. Color Doppler Imaging of Ophthalmic Artery Blood Flow Velocity
  130. Diplopie Iatrogenique: Possible Responsabilite Professionelle
  131. Severe Corneoconjunctival Xerosis After Biliopancreatic Bypass for Obesity (Scopinaro's Operation)
  132. Cocaine-associated retinal vascular occlusion: Report of two cases
  133. Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair